BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Fluconazole Impurity I | An impurity of the antifungal agent Fluconazole. Fluconazole is a triazole antifungal agent that is effective against most Candida strains. Group: Pharmaceutical. CAS No. 150168-54-0. Pack Sizes: 100 mg. Product ID: B2694-471657. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Flucytosine Impurities | Flucytosine Impurities are integral in the biomedical field for assessing the purity and efficacy of flucytosine, an antifungal medication. These impurities help in identifying degradation pathways and ensure drug safety in treating infections like cryptococcal meningitis. Detailed impurity profiling supports the development of robust quality control measures in pharmaceutical manufacturing. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fludarabine Impurities | Fludarabine Impurities, subtle yet significant chemical entities, arise during the synthesis and refinement of Fludarabine, a vital chemotherapeutic used against chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma. In-depth comprehension and meticulous regulation of these impurities are paramount in the biomedical field, ensuring optimal drug performance and safeguarding patient health. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fludrocortisol Impurities | Fludrocortisol Impurities are critical in the biomedical industry for the qualitative analysis of fludrocortisone acetate, a crucial medication used in treating conditions like Addison's disease and congenital adrenal hyperplasia. These impurities aid in ensuring the drug's purity and effectiveness through rigorous quality control processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fludrocortisone Impurities | Fludrocortisone Impurities are critical in the pharmaceutical industry for quality control and assurance during fludrocortisone production. These impurities aid in understanding fludrocortisone's synthetic pathways and degradation. Fludrocortisone, a corticosteroid, is primarily involved in treating conditions such as Addison's disease and salt-losing adrenogenital syndrome. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluensulfone | Fluensulfone is a nematicide of the 1,3-thiazole class. Fluensulfone is used in agriculture for the control of a variety of plant parasitic nematodes. Group: Pharmaceutical. CAS No. 318290-98-1. Pack Sizes: 25 mg. Product ID: B0084-471682. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| flufenoxuron | Flufenoxuron is used as an insecticide. Group: Pharmaceutical. CAS No. 101463-69-8. Pack Sizes: 5 g. Product ID: B2699-053028. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flumatinib Impurities | Flumatinib Impurities, integral to the complex development and quality assurance of the selective tyrosine kinase inhibitor flumatinib, demand meticulous analysis. This scrutiny guarantees the drug's safety and effectiveness, crucial in chronic myeloid leukemia treatment, thereby reinforcing the robustness of oncological strategies in combating such malignancies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flumequine Impurities | Flumequine Impurities, crucial within the biomedical spectrum, play an instrumental role in dissecting and characterizing the synthetic intricacies of the antibacterial Flumequine. Their profound impact lies in elucidating drug stability, efficacy, and safety parameters, essential for quality assurance, thereby aiding in the development of superior and safer antibacterial solutions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flumethasone Impurities | Flumethasone Impurities are critical reference standards in pharmaceutical development and quality control, ensuring the safety and efficacy of corticosteroid drugs for inflammatory and allergic disorders. These impurities aid in evaluating drug purity and stability, supporting the synthesis and formulation of flumethasone-based therapeutic agents. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flunarizine Impurities | Flunarizine Impurities are crucial in the biomedical field for ensuring the safety and efficacy of flunarizine, a drug primarily used to treat migraines and balance disorders. These impurities' analysis facilitates enhanced drug purity, quality control, and compliance with pharmaceutical standards, driving advancements in therapeutic formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flunixin Impurities | Flunixin Impurities are critical for the quality control and research of anti-inflammatory medications in veterinary medicine, particularly non-steroidal anti-inflammatory drugs (NSAIDs). These impurities are essential in the development and refinement of drugs aimed at managing inflammatory conditions in animals, such as bovine respiratory disease and equine colic. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluocinolone | Fluocinolone is a medication for use in the treatment of itching, redness, dryness, crusting, scaling, inflammation and skin conditions. Group: Pharmaceutical. CAS No. 807-38-5. Pack Sizes: 100 mg. Product ID: B0046-077765. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluocinonide Impurities | Fluocinonide Impurities hold a pivotal role in pharmaceutical sciences, meticulously scrutinized for ensuring the optimal purity and efficacy of fluocinonide-based therapies. Their examination is crucial in refining corticosteroid formulations, aimed at ameliorating inflammatory dermatoses such as eczema and psoriasis, thereby substantially elevating the safety and therapeutic effectiveness of these pharmacological interventions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluocortolone Impurities | Fluocortolone impurities are crucial analytical components in biomedical research, aiding in the refinement and development of corticosteroid medications. These impurities help identify and quantify undesired components, ensuring the purity and efficacy of drugs formulated to treat inflammation, eczema, and various allergic conditions, thereby enhancing patient safety and therapeutic outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluorometholone | Fluorometholone is a corticosteroid, most often used after laser-based refractive surgery. It is marketed under the brand names FML (Allergan) and Flarex (Alcon). Fluorometholone acetate ophthalmic suspension is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye. Group: Pharmaceutical. CAS No. 426-13-1. Pack Sizes: 10 g. Product ID: B2692-301378. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluorometholone Acetate | Fluorometholone acetate is a synthetic corticosteroid used in the treatment of steroid responsive inflammatory conditions of the eye. Group: Pharmaceutical. CAS No. 3801-6-7. Pack Sizes: 250 mg. Product ID: B2692-393472. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluorometholone Impurities | Fluorometholone Impurities, crucial in the biomedical domain, underpin the quality control and safety assessments of fluorometholone formulations. These entities are indispensable in verifying therapeutic purity and integrity, particularly in ophthalmic inflammation and allergic conjunctivitis treatments, thereby ensuring efficacy through rigorous analytical scrutiny. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluorometholone Impurity A | An impurity in the synthesis of Fluorometholone, a glucocorticoid used for the treatment of eye conditions caused by inflammation. Group: Pharmaceutical. CAS No. 6870-94-6. Pack Sizes: 25 mg. Product ID: NP3143. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluorouracil Impurities | Fluorouracil Impurities hold significant relevance in biomedical investigations, serving as a cornerstone for comprehending the synthesis and stability attributes of fluorouracil. This key chemotherapeutic agent is pivotal in treating colon, breast, and skin cancers. Analyzing these impurities enhances formulation refinement, ensuring therapeutic efficacy and advancing oncological treatment paradigms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluosemide Impurities | Fluosemide Impurities hold a crucial position within biomedical sciences, functioning as essential reference standards for diuretic quality control, notably Furosemide. These impurities are instrumental in detecting chemical modifications during drug formulation, thereby safeguarding both the efficacy and safety of Furosemide throughout its synthesis and analytical evaluation processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flupentixol Impurities | Flupentixol Impurities are integral to the quality assessment and development of antipsychotic medications. These impurities help in understanding drug safety, efficacy, and stability, ensuring that therapeutic agents treating psychiatric disorders, such as schizophrenia and other psychosis-related conditions, maintain their intended pharmaceutical properties without deleterious side effects. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluphenazine-[d8] Dihydrochloride | Fluphenazine-[d8] Dihydrochloride is the labelled analogue of Fluphenazine. Fluphenazine is an antipsychotic medication. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: BLP-005488. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluphenazine Decanoate Impurity 3 | Fluphenazine Decanoate Impurity 3 is one of Fluphenazine impurities. Fluphenazine is a phenothiazine antipsychotic, a dopaminergic antagonist and an antiviral agent. Group: Pharmaceutical. CAS No. 76013-31-5. Pack Sizes: 5 mg. Product ID: B0963-151110. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluphenazine Impurities | Fluphenazine Impurities, as ancillary chemical entities, hold essential roles in the meticulous quality assurance and safety evaluations of fluphenazine, extensively employed in psychotic disorder therapies such as schizophrenia. Their presence is pivotal in verifying therapeutic efficacy and chemical purity, thereby safeguarding the pharmaceutical utility and integrity of fluphenazine. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flupirtine Impurities | Flupirtine Impurities are critical in pharmaceutical research and development to ensure Flupirtine's efficacy as a non-opioid analgesic used in managing chronic pain and fibromyalgia. These impurities help improve drug safety profiles by assessing purity, stability, and potential side effects, thereby enhancing patient treatment outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluralaner | Fluralaner is a systemic insecticide and acaricide. It can be used for flea treatment in dogs. Uses: Flea treatment in dogs. Group: Pharmaceutical. CAS No. 864731-61-3. Pack Sizes: 100 mg. Product ID: B0084-476691. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flurbiprofen Impurities | Flurbiprofen Impurities are critical in pharmaceutical research for ensuring drug purity and safety. These impurities help in the identification, quantification, and characterization of undesired components or degradation products in Flurbiprofen formulations, aiding in the optimization of anti-inflammatory drugs used primarily for conditions like arthritis and musculoskeletal pain. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flurbiprofen Impurity C | Flurbiprofen Impurity C is an impurity of Flurbiprofen. Group: Pharmaceutical. CAS No. 61466-95-3. Pack Sizes: 250 mg. Product ID: B0965-471758. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flurbiprofen Sodium | Flurbiprofen Sodium is a non-steroidal anti-inflammatory drug (NSAID), which is mainly used as an antibiotic in eye surgery and is also an anti-inflammatory drug. Group: Pharmaceutical. CAS No. 56767-76-1. Pack Sizes: 5 g. Product ID: BBF-03906. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluroxypyr-[13C2] | Fluroxypyr-[13C2] is the labelled analogue of Fluroxypyr, which could be used as a herbicide as well as a synthetic auxin. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BLP-012364. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flutamide Impurities | Flutamide Impurities, crucial in the biomedical sector, assist in developing and evaluating the quality of flutamide, a nonsteroidal antiandrogen used primarily to treat prostate cancer. These impurities facilitate a deeper understanding of drug stability and efficacy, ensuring safer and more effective therapeutic outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone furoate | Fluticasone furoate is a synthetic corticosteroid derived from fluticasone, used for the treatment of seasonal allergic rhinitis. Uses: For treatment of seasonal allergic rhinitis. Group: Pharmaceutical. CAS No. 397864-44-7. Pack Sizes: 50 mg. Product ID: B0084-475694. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone propionate | Fluticasone propionate (Flonase, Veramyst) is a synthetic corticosteroid which is derived from fluticasone used to treat asthma and allergic rhinitis (hay fever). Uses: The treatment of asthma and allergic rhinitis. Group: Pharmaceutical. CAS No. 80474-14-2. Pack Sizes: 100 mg. Product ID: NP3130. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity A | Fluticasone Propionate EP Impurity A is an impurity formed in the synthesis of Fluticasone propionate. Group: Pharmaceutical. CAS No. 65429-42-7. Pack Sizes: 250 mg. Product ID: B2694-074555. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity B | Fluticasone Propionate EP Impurity B is an impurity formed in the synthesis of Fluticasone propionate. Group: Pharmaceutical. CAS No. 948566-12-9. Pack Sizes: 20 mg. Product ID: B0968-471779. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity C | Fluticasone Propionate EP Impurity C is an impurity of Fluticasone, a man-made glucocorticoid used to treat nasal symptoms. Group: Pharmaceutical. CAS No. 80474-24-4. Pack Sizes: 25 mg. Product ID: B1370-471778. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity D | Fluticasone Propionate EP Impurity D is an impurity of Fluticasone, a man-made glucocorticoid used to treat nasal symptoms. Group: Pharmaceutical. CAS No. 73205-13-7. Pack Sizes: 25 mg. Product ID: B1370-284468. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity E | Fluticasone Propionate EP Impurity E is an impurity of Fluticasone Propionate. Fluticasone Propionate is a synthetic corticosteroid which is derived from fluticasone used to treat asthma and allergic rhinitis (hay fever). Group: Pharmaceutical. CAS No. 105613-90-9. Pack Sizes: 25 mg. Product ID: B1370-257528. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity F | An impurity of Fluticasone, a corticosteroid used to treat symptoms of allergies like sneezing, itchy red eyes, and itchy. Group: Pharmaceutical. CAS No. 1219174-94-3. Pack Sizes: 25 mg. Product ID: B2694-471774. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity G | Fluticasone Propionate EP Impurity G is an impurity of Fluticasone Propionate. Fluticasone Propionate is a synthetic corticosteroid which is derived from fluticasone used to treat asthma and allergic rhinitis (hay fever). Group: Pharmaceutical. CAS No. 220589-37-7. Pack Sizes: 1 mg. Product ID: B0968-471776. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity H | Fluticasone Propionate EP Impurity H is an impurity of fluticasone propionate, an exalted synthetic corticosteroid. Fluticasone propionate is an esteemed therapeutic agent frequently administered to treat respiratory afflictions such as asthma and allergic rhinitis. Group: Pharmaceutical. CAS No. 201812-64-8. Pack Sizes: 5 mg. Product ID: B1370-471782. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate Impurities | Fluticasone Propionate Impurities, essential in the realm of biomedical quality control, emphasize the meticulous evaluation of fluticasone formulations. These impurities are pivotal in the treatment of respiratory ailments such as asthma and COPD, ensuring stringent adherence to pharmaceutical standards, thereby preserving drug efficacy, therapeutic effectiveness, and manufacturing precision within the pharmaceutical sphere. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate Intermediate | Fluticasone Propionate Intermediate is an impurity of fluticasone, a man-made glucocorticoid used to treat nasal symptoms. Uses: An intermediate in the synthesis of fluticasone propionate. Group: Pharmaceutical. CAS No. 80474-45-9. Pack Sizes: 100 mg. Product ID: B2694-077715. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Flutriafol Impurities | Flutriafol Impurities, derived during the synthesis of the antifungal drug Flutriafol, play a critical role in drug efficacy studies and quality control processes. These impurities are pivotal in ensuring the pharmaceutical integrity and safety of Flutriafol, which is utilized to treat various fungal infections in plant and animal health. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fluvastatin Impurities | Fluvastatin Impurities are vital in the biomedical industry for their role in assessing the purity and safety of fluvastatin, a medication used to lower cholesterol and prevent cardiovascular diseases. These impurities provide insights into drug stability, efficacy, and potential side effects, thereby ensuring optimal therapeutic outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| FMK | FMK is a potent, highly specific and irreversible ribosomal s6 kinase (RSK) inhibitor that covalently modifies the C-terminal kinase domain of RSK. Its IC50 value is 15 nM. It could prevent the activation of the N-terminal kinase domain of RSK by the C-terminal kinase domain, but does not affect the activity of the N-terminal domain. It binds in the CTKD ATP-binding site and inhibits RSK autophosphorylation at Ser386. It induces significant apoptosis in human FGFR3-expressing, t(4;14)-positive multiple myeloma cells. It is used to determine the role of RSK as a direct regulator of NHE1 phosphorylation and sarcolemmal NHE activity in this cell type, in response to 1-adrenergic stimulation. Uses: Fmk could prevent the activation of the n-terminal kinase domain of rsk by the c-terminal kinase domain, but does not affect the activity of the n-terminal domain. it is used to determine the role of rsk as a direct regulator of nhe1 phosphorylation and sarcolemmal nhe activity in this cell type, in response to 1-adrenergic stimulation. Group: Pharmaceutical. CAS No. 821794-92-7. Pack Sizes: 10 mg. Product ID: B0084-455721. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-1(1-Boc-piperidin-4-yl)-DL-glycine | Fmoc-1(1-Boc-piperidin-4-yl)-DL-glycine (CAS# 204058-24-2 ) is a useful research chemical. Group: Pharmaceutical. CAS No. 204058-24-2. Pack Sizes: 1 g. Product ID: BAT-007291. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-2,6-dimethyl-L-tyrosine | Fmoc-2,6-dimethyl-L-tyrosine, a derivative of tyrosine, is extensively utilized in peptide composite processes. In a myriad of studies, the peptide is known to be an effective building block in the assembly of bioactive peptides or proteins. Its application has been discovered in the realm of therapeutics too, working as a primary ingredient in drugs aiming to cure serious diseases such as cancer and neurological disorders. Group: Pharmaceutical. CAS No. 206060-54-0. Pack Sizes: 250 mg. Product ID: BAT-006161. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-3-(3'-Quinolyl)-L-Alanine | Fmoc-3-(3'-Quinolyl)-L-Alanine. Group: Pharmaceutical. CAS No. 281655-61-6. Pack Sizes: 1 g. Product ID: BAT-014248. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-3,4-dehydro-L-proline | Fmoc-3,4-dehydro-L-proline, a chemical intermediary employed in the synthesis of peptides within the biomedical sector, displays considerable promise with regard to the treatment of conditions such as cancer and Alzheimer's disease. Its potential medical applications are extensive and merit further exploration. Group: Pharmaceutical. CAS No. 135837-63-7. Pack Sizes: 1 g. Product ID: BAT-007331. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-4-Borono-L-Phenylalanine | Fmoc-4-Borono-L-Phenylalanine, a derivative of amino acid utilized for peptide synthesis and asymmetric synthesis catalysis, has garnered significant interest due to its promising therapeutic effects on cancer and diabetes. Numerous studies have been conducted on this compound to explore its potential for treating these diseases. Group: Pharmaceutical. CAS No. 273221-71-9. Pack Sizes: 100 mg. Product ID: BAT-008403. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Dha-OH | Fmoc-Dha-OH, a pivotal intermediate, is used for synthesizing a plethora of biologically active compounds encompassing antimicrobial peptides, dipeptidyl peptidase IV inhibitors, and enzyme inhibitors. Researchers have employed it to fabricate Fmoc-Dha-OH-derived peptidomimetics manifested by the impeding activity against a myriad of cancer cell lines. The said compound holds sheer potential for the design and development of novel pharmaceutical agents targeting numerous diseases. Group: Pharmaceutical. CAS No. 261522-33-2. Pack Sizes: 500 mg. Product ID: BAT-008269. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-D-Lys(Dde)-OH | Fmoc-D-Lys(Dde)-OH, a vital reagent for peptide synthesis, restricts the D-Lysine residue for selective introduction of D-amino acids into the peptide chains. Moreover, the Dde protection group enables mild deprotection under specific conditions during solid-phase synthesis, thus augmenting its applicability. This characteristic formulation, thus, serves as a fundamental component in the preparation of specialized peptides. Group: Pharmaceutical. CAS No. 333973-51-6. Pack Sizes: 5 g. Product ID: BAT-003698. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-(Dmb)Gly-OH | Fmoc-(Dmb)Gly-OH. Group: Pharmaceutical. CAS No. 166881-42-1. Pack Sizes: 10 g. Product ID: BAT-008867. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-His-Aib-OH TFA | An intermediate in the synthesis of Semaglutide, an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 1446013-08-6. Pack Sizes: 100 mg. Product ID: B2692-383273. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH | Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH is a yellowish medical intermediate in the synthesis of Tirzepatide. Tirzepatide is a dual GIP and GLP-1 receptor agonist and a drug candidate for the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 2460751-66-8. Pack Sizes: 1 g. Product ID: B1370-449764. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-amido-PEG12-propionic acid | Fmoc-N-amido-PEG12-propionic acid is a PEG linker containing a protected amino group and a carboxylic acid. The carboxylic acid can be reacted with amino groups in the presence of activators. Group: Pharmaceutical. CAS No. 1952360-91-6. Pack Sizes: 100 mg. Product ID: B2699-278820. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-amido-PEG2-acetic acid | Fmoc-AEEA-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Group: Pharmaceutical. CAS No. 166108-71-0. Pack Sizes: 10 g. Product ID: BAT-007778. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-amido-PEG4-propionic acid | Fmoc-NH-PEG4-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Group: Pharmaceutical. CAS No. 557756-85-1. Pack Sizes: 5 g. Product ID: BADC-01135. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-Me-3-(4-py)-L-Ala | Fmoc-N-Me-3-(4-py)-L-Ala, a synthetic molecule, finds widespread use in the synthesis of peptides and proteins. Owing to its crucial role as a fundamental building block in solid-phase peptide synthesis, it has emerged as a potent weapon in the battle against numerous human maladies such as cancer and infectious diseases. With versatile functionality and chemical reactivity, the compound facilitates modifications and attachment to the peptide chain, rendering it a prized asset in the biomedical industry and a tool much sought after by researchers. Group: Pharmaceutical. CAS No. 2381854-90-4. Pack Sizes: 1 g. Product ID: BAT-009000. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-Me-Dab(Boc)-OH | Fmoc-N-Me-Dab(Boc)-OH, a peptide derivative, finds extensive applications in the pharmaceutical and biologically active compound synthesis arena. One can leverage it as a fundamental building block to engineer peptide-based drugs with proven anti-tumor activity. The versatility of Fmoc-N-Me-Dab(Boc)-OH renders it an indispensable tool in the scientific community, and its intricate molecular structure continues to inspire novel applications in the field of drug discovery and development. Group: Pharmaceutical. CAS No. 2044702-38-5. Pack Sizes: 100 mg. Product ID: BAT-008506. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-Me-D-Lys(Boc)-OH | Fmoc-N-Me-D-Lys(Boc)-OH is a multifaceted chemical agent that is employed in the synthetic production of proteins and peptides. This chemical is highly valued in the medical industry for its efficacy in treating infectious diseases and cancers. Scientists have also harnessed its potential for biochemical research pertaining to the design of pharmaceuticals directed towards targeted proteins. Group: Pharmaceutical. CAS No. 1793105-27-7. Pack Sizes: 5 g. Product ID: BAT-008511. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Pal-Linker | It is a reagent for the mild solid-phase synthesis of C-terminal peptide amides. Group: Pharmaceutical. CAS No. 115109-65-4. Pack Sizes: 5 g. Product ID: BAT-004733. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-PNA-A(Bhoc)-OH | A Fmoc PNA monomer that is a building block for the synthesis of PNA oligomers. Uses: fmoc-pna-a(bhoc)-oh is an fmoc pna monomer containing an fmoc (9-fluorenylmethoxycarbonyl) group for solid phase peptide synthesis and a bhoc (benzhydryloxycarbonyl) protecting group for specific applications.
1. solid phase peptide synthesis (spps): the solid phase synthesis of pna oligomers is one of the primary uses of fmoc-pna-a(bhoc)-oh. stepwise assembly of pna sequences on a solid. Group: Pharmaceutical. CAS No. 186046-82-2. Pack Sizes: 1 g. Product ID: BAT-008536. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-PNA-C(Bhoc)-OH | A Fmoc PNA monomer that is a building block for the synthesis of PNA oligomers. Group: Pharmaceutical. CAS No. 186046-81-1. Pack Sizes: 1 g. Product ID: BAT-008537. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-PNA-G(Bhoc)-OH | A Fmoc PNA monomer that is a building block for the synthesis of PNA oligomers. Group: Pharmaceutical. CAS No. 186046-83-3. Pack Sizes: 1 g. Product ID: BAT-014015. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-PNA-T-OH | A Fmoc PNA monomer that is a building block for the synthesis of PNA oligomers. Group: Pharmaceutical. CAS No. 169396-92-3. Pack Sizes: 1 g. Product ID: BAT-008538. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-S-trityl-L-penicillamine | Fmoc-S-trityl-L-penicillamine is a derivative of D-Penicillamine, which is a penicillin metabolite used in the treatment of Wilson's disease, Cystinuria, Scleroderma and arsenic poisoning. Group: Pharmaceutical. CAS No. 201531-88-6. Pack Sizes: 5 g. Product ID: BAT-007492. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Thr[GalNAc(Ac)3-α-D]-OH | Fmoc-Thr[GalNAc(Ac)3-α-D]-OH is a biomedical compound used for the research of diseases involving abnormal glycosylation processes. It functions as a glycosylation inhibitor, targeting enzymes responsible for glycan modification. This product aids in the study and understanding of glycosylation-related disorders. Group: Pharmaceutical. CAS No. 116783-35-8. Pack Sizes: 25 mg. Product ID: BAT-008014. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.